380 related articles for article (PubMed ID: 14664205)
1. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.
Abrams-Ogg AC
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
Hux BD; Martin LG
J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
[TBL] [Abstract][Full Text] [Related]
4. Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs.
Davidow EB; Brainard B; Martin LG; Beal MW; Bode A; Ford MJ; Ramsey N; Fagella A; Jutkowitz A
J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):116-25. PubMed ID: 23016747
[TBL] [Abstract][Full Text] [Related]
5. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of fresh platelet concentrate administration in dogs: Patient characteristics, outcomes, and transfusion practices in 189 transfusion episodes (2008-2019).
Saint-Pierre LM; Farrell KS; Hopper K; Reagan KL
J Vet Emerg Crit Care (San Antonio); 2023; 33(3):360-370. PubMed ID: 36799875
[TBL] [Abstract][Full Text] [Related]
8. Cryopreserved platelet concentrate transfusions in 43 dogs: a retrospective study (2007-2013).
Ng ZY; Stokes JE; Alvarez L; Bartges JW
J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):720-8. PubMed ID: 27376965
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion in hematology, oncology and surgery.
Wandt H; Schäfer-Eckart K; Greinacher A
Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
[TBL] [Abstract][Full Text] [Related]
10. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
11. Overview of platelet transfusion.
McCullough J
Semin Hematol; 2010 Jul; 47(3):235-42. PubMed ID: 20620434
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR
Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952
[TBL] [Abstract][Full Text] [Related]
15. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
[TBL] [Abstract][Full Text] [Related]
16. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
17. Relationship between platelet count and bleeding risk in thrombocytopenic patients.
Slichter SJ
Transfus Med Rev; 2004 Jul; 18(3):153-67. PubMed ID: 15248165
[TBL] [Abstract][Full Text] [Related]
18. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
19. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
20. New strategies for prophylactic platelet transfusion in patients with hematologic diseases.
Wandt H; Ehninger G; Gallmeier WM
Oncologist; 2001; 6(5):446-50. PubMed ID: 11675523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]